Literature DB >> 16600179

A novel interaction [corrected] of nucleolin with Rad51.

Ananya De1, Sarah L Donahue, Azah Tabah, Nancy E Castro, Naomi Mraz, Jennifer L Cruise, Colin Campbell.   

Abstract

Nucleolin associates with various DNA repair, recombination, and replication proteins, and possesses DNA helicase, strand annealing, and strand pairing activities. Examination of nuclear protein extracts from human somatic cells revealed that nucleolin and Rad51 co-immunoprecipitate. Furthermore, purified recombinant Rad51 associates with in vitro transcribed and translated nucleolin. Electroporation-mediated introduction of anti-nucleolin antibody resulted in a 10- to 20-fold reduction in intra-plasmid homologous recombination activity in human fibrosarcoma cells. Additionally, introduction of anti-nucleolin antibody sensitized cells to death induced by the topoisomerase II inhibitor, amsacrine. Introduction of anti-Rad51 antibody also reduced intra-plasmid homologous recombination activity and induced hypersensitivity to amsacrine-induced cell death. Co-introduction of anti-nucleolin and anti-Rad51 antibodies did not produce additive effects on homologous recombination or on cellular sensitivity to amsacrine. The association of the two proteins raises the intriguing possibility that nucleolin binding to Rad51 may function to regulate homologous recombinational repair of chromosomal DNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600179     DOI: 10.1016/j.bbrc.2006.03.113

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Nucleolin: The most abundant multifunctional phosphoprotein of nucleolus.

Authors:  Marjan M Tajrishi; Renu Tuteja; Narendra Tuteja
Journal:  Commun Integr Biol       Date:  2011-05

2.  Nucleolin is required for efficient nuclear egress of herpes simplex virus type 1 nucleocapsids.

Authors:  Ken Sagou; Masashi Uema; Yasushi Kawaguchi
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

3.  Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs.

Authors:  Jian-Yu Xu; Shan Lu; Xiang-Ying Xu; Song-Liu Hu; Bin Li; Wen-Xin Li; Joe Y Chang
Journal:  Tumour Biol       Date:  2016-02-04

4.  Nucleolin inhibits G4 oligonucleotide unwinding by Werner helicase.

Authors:  Fred E Indig; Ivana Rybanska; Parimal Karmakar; Chakravarty Devulapalli; Haiqing Fu; France Carrier; Vilhelm A Bohr
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

5.  Nucleolin participates in DNA double-strand break-induced damage response through MDC1-dependent pathway.

Authors:  Junya Kobayashi; Hiroko Fujimoto; Jun Sato; Ikue Hayashi; Sandeep Burma; Shinya Matsuura; David J Chen; Kenshi Komatsu
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

6.  RAD51AP2, a novel vertebrate- and meiotic-specific protein, shares a conserved RAD51-interacting C-terminal domain with RAD51AP1/PIR51.

Authors:  Oleg V Kovalenko; Claudia Wiese; David Schild
Journal:  Nucleic Acids Res       Date:  2006-09-20       Impact factor: 16.971

Review 7.  Roles of nucleolin. Focus on cancer and anti-cancer therapy.

Authors:  Zhuo Chen; XinHua Xu
Journal:  Saudi Med J       Date:  2016-12       Impact factor: 1.484

8.  A recurrent de novo missense mutation in UBTF causes developmental neuroregression.

Authors:  Camilo Toro; Roderick T Hori; May Christine V Malicdan; Cynthia J Tifft; Amy Goldstein; William A Gahl; David R Adams; Harper B Fauni; Lynne A Wolfe; Jianfeng Xiao; Mohammad M Khan; Jun Tian; Kevin A Hope; Lawrence T Reiter; Michel G Tremblay; Tom Moss; Alexis L Franks; Chris Balak; Mark S LeDoux
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

Review 9.  The Nucleolus: In Genome Maintenance and Repair.

Authors:  Maria Tsekrekou; Kalliopi Stratigi; Georgia Chatzinikolaou
Journal:  Int J Mol Sci       Date:  2017-07-01       Impact factor: 5.923

10.  C23 promotes tumorigenesis via suppressing p53 activity.

Authors:  Qun Li; Yan Zhu; Lili Hou; Juan Wang; Guilin Hu; Xing Fang; Yamin Hu; Tingting Tao; Xin Wei; Haitao Tang; Baojun Huang; Wanglai Hu
Journal:  Oncotarget       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.